注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Purple Biotech Ltd(原名:Kitov Pharma Ltd)是一家以色列的临床阶段公司,致力于开发克服肿瘤免疫逃逸和耐药性疼痛的药物。该公司的主要产品是NT-219 i CM-24。CM-24是一种单克隆抗体阻断素,而NT-219是一种具有两种主要抗癌途径的小分子双特异性抑制剂。该公司还是塞来昔布和苯磺酸氨氯地平的固定剂量组合Consensi的所有者,用于同时治疗骨关节炎疼痛和高血压。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Eric K. Rowinsky | 65 | 2019 | Independent Chairman of the Board |
Sunil Sharma | - | 2023 | Member of Scientific Advisory Board |
Robert E. Gagnon | 49 | 2021 | Independent Director |
Ori Hershkovitz | 48 | 2021 | Independent Director |
Steven Maron | - | 2023 | Member of Scientific Advisory Board |
Scott Faucett | - | 2014 | Member of Scientific Advisory Board |
Sean Welton | - | 2014 | Member of Scientific Advisory Board |
Suzana Nahum-Zilberberg | 52 | 2021 | Independent Director |
Eyal Gottlieb | - | 2023 | Member of Scientific Advisory Board |
Yael Margolin | 70 | 2023 | Independent Director |
Simcha Rock | 74 | 2013 | Independent Director |
Ido Agmon | 47 | 2016 | Independent Director |
Isaac Israel | 46 | 2012 | Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核